AAnnals of Internal Medicine3/30/2026Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to TirzepatideKristina S. Boye·Anita Y.M. Kwan·Palash Sharma·Karthik Chivukula·Emer B. FarrellRead at Annals of Internal MedicineTagsDiabetes Treatment and ManagementEndocrinology, Diabetes and Metabolism
